Dr. Jens Juul Holst, Professor at the Department of Biomedical Sciences and Senior Group Leader at Novo Nordisk Foundation Center for Basic Metabolic Research on the next breakthroughs in obesity treatment.

It’s clear the next breakthrough in obesity treatment will come from entirely new mechanisms that go beyond appetite suppression like VIAL-INHBE. Hear more from Dr. Jens Juul Holst, Professor at the Department of Biomedical Sciences and Senior Group Leader at Novo Nordisk Foundation Center for Basic Metabolic Research.
View on Linkedin

More Resources

Videos

Dr. Lee Kaplan, Director at Dartmouth Health’s Weight and Wellness Center, points to the myostatin/activin pathway as a promising target.

Videos

Dr. Arya M. Sharma, MD, DSc (hon), FRCPC, FCAHS, emphasizes how Vial’s INHBE siRNA directly impacts the function of adipose tissue to better address cellular hypertrophy and inflammation.

Videos

Dr. Scott Kahan, Director of the National Center for Weight and Wellness at Johns Hopkins Bloomberg School of Public Health, highlights the importance of new mechanisms of action beyond GLP-1 therapies.

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

This field is for validation purposes and should be left unchanged.

Name(Required)

Work email(Required)

Phone

Company(Required)

Which best describes you?(Required)

Message

By submitting, you are agreeing to our terms and privacy policy